Abstract
Background and Aims Chronic liver diseases (CLD) affect approximately 2% of the U.S. population and are associated with substantial burden of hospitalization and costs. We estimated the national burden and consequences of financial hardship from medical bills in individuals with CLD. Approach and Results Using the National Health Interview Survey from 2014 to 2018, we identified individuals with self‐reported CLD. We used complex weighted survey analysis to obtain national estimates of financial hardship from medical bills and other financial toxicity measures (eg, cost‐related medication nonadherence, personal and/or health care–related financial distress, food insecurity). We evaluated the association of financial hardship from medical bills with unplanned health care use and work productivity, accounting for differences in age, sex, race/ethnicity, insurance, income, education, and comorbidities. Of the 3,666 (representing 5.3 million) U.S. adults with CLD, 1,377 (representing 2 million [37%, 95% CI: 35%‐39%]) reported financial hardship from medical bills, including 549 (representing 740,000 [14%, 95% CI: 13%‐16%]) who were unable to pay medical bills at all. Adults who were unable to pay medical bills had 8.4‐times higher odds of cost‐related medication nonadherence (adjusted OR [aOR], 8.39 [95% CI, 5.72‐12.32]), 6.3‐times higher odds of financial distress (aOR, 6.33 [4.44‐9.03]), and 5.6‐times higher odds of food insecurity (aOR, 5.59 [3.74‐8.37]), as compared to patients without financial hardship from medical bills. Patients unable to pay medical bills had 1.9‐times higher odds of emergency department visits (aOR, 1.85 [1.33‐2.57]) and 1.8‐times higher odds of missing work due to disease (aOR, 1.83 [1.26‐2.67]). Conclusions One in 3 adults with CLD experience financial hardship from medical bills, and frequently experience financial toxicity and unplanned healthcare use. These financial determinates of health have important implications in the context of value‐based care.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
